000			02950nam a2200301Ia 4500
003			MX-MdCICY
005			20250625164351.0
040			_cCICY
090			_aB-21217
245	1	0	_aThe chitin-binding domain of Bacillus thuringiensis ChiA74 inhibits gram-negative bacterial and fungal pathogens of humans and plants
490	0		_aInternational Journal of Biological Macromolecules. 254, 128049, 2024, DOI: 10.1016/j.ijbiomac.2023.128049
520	3		_aThe chitinase ChiA74 is synthesized by Bacillus thuringiensis and possesses a modular organization composed of four domains. In the C-terminal of the enzyme is located the chitin-binding domain (CBD), which has not been isolated as a single unit or characterized. Here, we aimed to isolate the ChiA74's CBD as a single unit, determine the binding properties, and evaluate its antimicrobial and hemolytic activities. We cloned the ChiA74's CBD and expressed it in Escherichia coli BL21. The single domain was purified, analyzed by SDS-PAGE, and characterized. The recombinant CBD (rCBD) showed a molecular mass of ?14 kDa and binds strongly to ?-chitin, with Kd and Bmax of ?4.7 ± 0.9 ?M and 1.5 ± 0.1 ?moles/g chitin, respectively. Besides, the binding potential (Bmax/Kd) was stronger for ?-chitin (?0.31) than microcrystalline cellulose (?0.19). It was also shown that the purified rCBD inhibited the growth of the clinically relevant Gram-negative bacteria (GNB) Vibrio cholerae, and V. parahemolyticus CVP2 with minimum inhibitory concentrations (MICs) of 121 ± 9.9 and 138 ± 3.2 ?g/mL, respectively, and of one of the most common GNB plant pathogens, Pseudomonas syringae with a MIC of 230 ± 13.8 ?g/mL. In addition, the rCBD possessed antifungal activity inhibiting the conidia germination of Fusarium oxysporum (MIC = 192 ± 37.5 ?g/mL) and lacked hemolytic and agglutination activities against human erythrocytes. The significance of this work lies in the fact that data provided here show for the first time that ChiA74's CBD from B. thuringiensis has antimicrobial activity, suggesting its potential use against significant pathogenic microorganisms. Future works will be focused on testing the inhibitory effect against other pathogenic microorganisms and elucidating the mechanism of action. © 2023 Elsevier B.V.
650	1	4	_aANTIBACTERIAL ACTIVITY
650	1	4	_aANTIFUNGAL ACTIVITY
650	1	4	_aBACILLUS THURINGIENSIS
650	1	4	_aCHITIN-BINDING DOMAIN
650	1	4	_aCHITINASE
700	1	2	_aMartínez-Zavala S.A.
700	1	2	_aOrtiz-Rodríguez T.
700	1	2	_aSalcedo-Hernández R.
700	1	2	_aCasados-Vázquez L.E.
700	1	2	_aDel Rincón-Castro M.C.
700	1	2	_aBideshi D.K.
700	1	2	_aBarboza-Corona J.E.
856	4	0	_uhttps://drive.google.com/file/d/1bYIbdHiSGJeYFIck0nTfTgD-dxTBQfin/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c55288 _d55288